
Are you looking to buy Pfizer stocks? Chech our BAMagazine with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:PFE! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Pfizer stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Myovant Sciences Ltd.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; a drug discovery collaboration with Sosei Group Corporation; and collaboration with LianBio. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Average volume
38.26 million shs
MARKET CAP
$193.32 billion
Stock exchange
NYSE
Buy this stock!
Below is a quick guide on how to buy NYSE:PFE stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Pfizer shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Pfizer – Search for “”NYSE:PFE”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Pfizer stocks with 0% commission!.
1 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
15 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Pfizer in the last year. There are currently 10 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” Pfizer stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PFE, but not buy additional shares or sell existing shares.
Wall Street analysts have given Pfizer a “Hold” rating, but there may be better short-term opportunities in the market. Some of BAMagazine’s past winning trading ideas have resulted in 5-15% weekly gains. BAMagazine just released five new trading ideas, but Pfizer wasn’t one of them. BAMagazine thinks five stocks may be even better buys in the how to buy stocks guide.
1 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:PFE stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Pfizer stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Pfizer stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “NYSE:PFE stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some NYSE:PFE stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:PFE is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Pfizer stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, April 27th 2021.
View our earnings forecast for Pfizer.
Pfizer Inc. (NYSE:PFE) issued its quarterly earnings data on Tuesday, February, 2nd. The biopharmaceutical company reported $0.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.46 by $0.04. The biopharmaceutical company had revenue of $11.68 billion for the quarter, compared to analysts’ expectations of $11.32 billion. Pfizer had a trailing twelve-month return on equity of 24.88% and a net margin of 17.85%. The firm’s quarterly revenue was up 11.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.55 earnings per share.
View Pfizer’s earnings history.
Pfizer’s stock was trading at $32.17 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PFE stock has increased by 8.4% and is now trading at $34.87.
Pfizer announced a quarterly dividend on Friday, December 11th. Investors of record on Friday, January 29th will be paid a dividend of $0.39 per share on Friday, March 5th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 4.47%. The ex-dividend date of this dividend is Thursday, January 28th. This is a boost from Pfizer’s previous quarterly dividend of $0.38.
View Pfizer’s dividend history.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:PFE stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Pfizer pays an annual dividend of $1.56 per share and currently has a dividend yield of 4.47%. PFE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Pfizer does not yet have a strock track record of dividend growth. The dividend payout ratio of Pfizer is 52.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Pfizer will have a dividend payout ratio of 50.98% next year. This indicates that Pfizer will be able to sustain or increase its dividend.
View Pfizer’s dividend history.
Pfizer updated its FY21 earnings guidance on Tuesday, February, 2nd. The company provided earnings per share (EPS) guidance of $3.10-3.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.97. The company issued revenue guidance of $59.4-61.4 billion, compared to the consensus revenue estimate of $48.51 billion.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
15 brokers have issued 12 month price objectives for Pfizer’s shares. Their forecasts range from $24.00 to $53.00. On average, they expect Pfizer’s share price to reach $39.53 in the next year. This suggests a possible upside of 13.4% from the stock’s current price.
View analysts’ price targets for Pfizer or view top-rated stocks among Wall Street analysts.
Pfizer’s management team includes the following people:
Dr. Albert Bourla D.V.M., DVM, Ph.D., Chairman & CEO (Age 59, Pay $5.84M)
Mr. John D. Young, Group Pres & Chief Bus. Officer (Age 56, Pay $3.36M)
Mr. Frank A. D’Amelio, CFO & Exec. VP of Global Supply (Age 63, Pay $3.84M)
Dr. Mikael Dolsten, Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical (Age 62, Pay $3.66M)
Ms. Jennifer B. Damico, Sr. VP, Controller & Principal Accounting Officer (Age 53)
Ms. Lidia L. Fonseca, Exec. VP and Chief Digital & Technology Officer (Age 52)
Mr. Charles E. Triano, Sr. VP of Investor Relations
Mr. Douglas M. Lankler, Exec. VP & Gen. Counsel (Age 55)
Mr. Rady A. Johnson, Exec. VP and Chief Compliance, Quality & Risk Officer (Age 59)
Dr. Alexander Rod MacKenzie, Chief Devel. Officer & Exec. VP of Global Product Devel. (Age 61)
358 employees have rated Pfizer CEO Albert Bourla on Glassdoor.com. Albert Bourla has an approval rating of 92% among Pfizer’s employees. This puts Albert Bourla in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
Some companies that are related to Pfizer include Johnson & Johnson (JNJ), Eli Lilly and (LLY), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN).
View all of PFE’s competitors.
1 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Based on aggregate information from BAMagazine watchlists, some companies that other Pfizer investors own include AT&T (T), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Intel (INTC), Verizon Communications (VZ), AbbVie (ABBV), The Walt Disney (DIS), Exxon Mobil (XOM), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).
Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol “PFE.”
Pfizer’s stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.14%), Swiss National Bank (0.40%), Sumitomo Mitsui Trust Holdings Inc. (0.35%), California Public Employees Retirement System (0.35%), Boston Partners (0.26%) and Robeco Institutional Asset Management B.V. (0.17%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Jennifer B Damico, Mikael Dolsten, Pfizer Inc, Rady A Johnson, Ronald E Blaylock and Scott Gottlieb.
View institutional ownership trends for Pfizer.
PFE stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., FIL Ltd, Boston Partners, Sumitomo Mitsui Trust Holdings Inc., PGGM Investments, Russell Investments Group Ltd., Hexavest Inc., and NN Investment Partners Holdings N.V.. Company insiders that have sold Pfizer company stock in the last year include Douglas M Lankler, and Jennifer B Damico.
View insider buying and selling activity for Pfizer or view top insider-selling stocks.
PFE stock was acquired by a variety of institutional investors in the last quarter, including State of Wisconsin Investment Board, California Public Employees Retirement System, Retirement Systems of Alabama, National Mutual Insurance Federation of Agricultural Cooperatives, Kestra Advisory Services LLC, Segantii Capital Management Ltd, First Trust Advisors LP, and KAMES CAPITAL plc. Company insiders that have bought Pfizer stock in the last two years include Pfizer Inc, Ronald E Blaylock, and Scott Gottlieb.
View insider buying and selling activity for Pfizer or or view top insider-buying stocks.
Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, DEGiro Review, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review and many more. Read one of the reviews to find out everything about the broker and start buying stocks now.
At BAMagazine.com we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How to buy Pfizer stocks?
The safest and easiest way to buy NYSE:PFE stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Opening an account with one of these brokers is a smart move, they have been active for more then 10 years, are very safe to use and they have the best platform for novice and experienced traders. If you want to learn more then we suggest you to read our eToro or DeGiro guides.
Where to buy Pfizer stock?
You will first want to find a licensed broker that supports Pfizer stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:PFE stocks in a safe and complete environment.
Is NYSE:PFE stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:PFE stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Pfizer stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:PFE is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Pfizer stock.
How do you trade Pfizer stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Pfizer stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:PFE stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Pfizer stock?
To sell your NYSE:PFE stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Pfizer stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:PFE stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
![]() | Our score ★★★★★ | |
![]() | Our score ★★★★★ | |
![]() | Our score ★★★★★ |
Newsletter
![]() |
Our score |
0% commission |
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
BAMagazine Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
BAMagazine Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 BAMagazine.Finance | All rights reserved.